A detailed history of Redwood Investments, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Redwood Investments, LLC holds 94,554 shares of TGTX stock, worth $3.71 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
94,554
Previous 93,668 0.95%
Holding current value
$3.71 Million
Previous $2.19 Million 29.95%
% of portfolio
0.83%
Previous 0.69%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$21.31 - $35.09 $18,880 - $31,089
886 Added 0.95%
94,554 $2.85 Million
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $1.61 Million - $2.37 Million
93,668 New
93,668 $2.19 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.7B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.